Active, Not Recruiting
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab
NCT04130516
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States